Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealthEquityFRA:2HE -0.56%93 Debt-to-Equity is 0.48 as of Apr. 2026, which is 9% below its 10-year median of 0.53. GuruFocus rates FRA:2HE with a GF Score™ of 93/100 and a GF Value™ of €89.01 (Fairly Valued). The stock has 4 warning signs investors should review. Among 563 Healthcare Providers & Services companies, HealthEquity ranks worse than 52.75% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for HealthEquity's Debt-to-Equity or its related term are showing as below:
FRA:2HE'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04 Med: 0.53 Max: 1.29
Current: 0.48
During the past 13 years, the highest Debt-to-Equity Ratio of HealthEquity was 1.29. The lowest was 0.04. And the median was 0.53.
FRA:2HE's Debt-to-Equity is ranked worse than 52.75% of 563
companies
in the Healthcare Providers & Services industry
Industry Median: 0.42
vs FRA:2HE: 0.48
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
HealthEquity Debt-to-Equity Related Terms
HealthEquity Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for HealthEquity's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2HE vs TEM, TXG, HNGE: Debt-to-Equity Comparison
For the Health Information Services subindustry, HealthEquity's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthEquity Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where HealthEquity's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthEquity (FRA:2HE) has a Debt-to-Equity of 0.48 as of Apr. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on HealthEquity and its competitors. This is near median its historical median of 0.53. Over the past decade, HealthEquity's Debt-to-Equity has ranged from 0.04 to 1.29. According to the industry distribution chart, HealthEquity ranks #297 out of 563 companies in the Healthcare Providers & Services industry, placing it in the top 52.8%.
Is HealthEquity's Debt-to-Equity too high?
HealthEquity's current Debt-to-Equity of 0.48 is near median its 10-year median of 0.53. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 1.29. The Healthcare Providers & Services industry median Debt-to-Equity is 0.42. HealthEquity's value of 0.48 is 14.3% above this industry median. Based on the distribution chart, HealthEquity ranks #297 out of 563 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, HealthEquity has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Debt-to-Equity compare to TEM and TXG?
According to the Healthcare Providers & Services industry distribution chart, HealthEquity ranks #297 out of 563 companies for Debt-to-Equity. This places HealthEquity in the lower half of its industry. The industry median Debt-to-Equity is 0.42. HealthEquity's value of 0.48 is 14.3% above this benchmark. Historically, HealthEquity's own Debt-to-Equity has ranged from 0.04 to 1.29 over the past decade. While the company's 10-year median is 0.53 vs. the industry median of 0.42, HealthEquity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.42, based on 563 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthEquity's current Debt-to-Equity of 0.48 is 14.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on HealthEquity and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthEquity's current Debt-to-Equity is 0.48, which is near median its own 10-year median of 0.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
Based on GuruFocus' analysis, HealthEquity (FRA:2HE) is currently considered Fairly Valued. The stock's GF Value™ is €89.01, compared to a current price of €89.00 — trading 0% below its estimated fair value. The current Debt-to-Equity is 0.48, which is near median its 10-year median of 0.53 and 14.3% above the Healthcare Providers & Services industry median of 0.42. HealthEquity's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Debt-to-Equity is 0.48 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthEquity (FRA:2HE) Overvalued in 2026?
Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued.
The current stock price of €89.00 is trading 0% below its estimated GF Value™ of €89.01.
GuruFocus considers HealthEquity to be Fairly Valued.
Key valuation signals for FRA:2HE:
Debt-to-Equity: 0.48 (near median its 10-year median of 0.53)
GF Value™: €89.01 vs. price of €89.00 (0% below fair value)
Industry Position: 14.3% above the Healthcare Providers & Services median (#297 of 563)
No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
93GF Score
Get the complete analysis for FRA:2HE
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2HE has been successfully added to your 
